Literature DB >> 20936638

Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG.

Katherine R Goetzinger1, Ashima Singla, Sabrina Gerkowicz, Jeffrey M Dicke, Diana L Gray, Anthony O Odibo.   

Abstract

OBJECTIVE: To determine if a simplified model for predicting pre-eclampsia (PEC) can be developed by combining first-trimester serum analytes, pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotrophin (β-hCG), and maternal characteristics.
METHODS: A retrospective cohort study of patients seen for first-trimester aneuploidy screening from 2003 to 2009. The 5th, 10th, 90th, and 95th percentiles for the analyte multiples of the medians (MoMs) for our population were determined and evaluated for association with PEC. Univariate and backward stepwise logistic regression analyses were performed and the area under the receiver operating characteristic (ROC) curves [area under curve (AUC)] used to determine the best models for predicting PEC.
RESULTS: Among 4020 women meeting the inclusion criteria, outcome data was available for 3716 (93%). There were 293 cases of PEC. The final model identified a history of pre-gestational diabetes [aOR 2.6, 95% confidence interval (CI) 1.7-3.9], chronic hypertension (cHTN) (aOR 2.6, 95% CI 1.7-3.9), maternal body mass index (BMI) > 25 (aOR 2.5, 95% CI 1.9-3.4), African American race (aOR 1.8, 95% CI 1.3-2.6), and PAPP-A MoM < 10th percentile (aOR 1.6, 95% CI 1.1-2.4) to be significant predictors of PEC (AUC = 0.70, 95% CI 0.65-0.72).
CONCLUSION: Low first-trimester PAPP-A levels are associated with the development of PEC; however, the model was only modestly efficient in its predictive ability.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936638      PMCID: PMC3129136          DOI: 10.1002/pd.2627

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  17 in total

1.  First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications.

Authors:  C Y Ong; A W Liao; K Spencer; S Munim; K H Nicolaides
Journal:  BJOG       Date:  2000-10       Impact factor: 6.531

2.  First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.

Authors:  Nicholas J Cowans; Kevin Spencer
Journal:  Prenat Diagn       Date:  2007-03       Impact factor: 3.050

3.  Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks.

Authors:  L C Y Poon; R Akolekar; R Lachmann; J Beta; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2010-06       Impact factor: 7.299

Review 4.  Role of the IGF system in trophoblast invasion and pre-eclampsia.

Authors:  J C Irwin; L F Suen; N A Martina; S P Mark; L C Giudice
Journal:  Hum Reprod       Date:  1999-12       Impact factor: 6.918

5.  Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

Authors:  Gordon C S Smith; Emily J Stenhouse; Jennifer A Crossley; David A Aitken; Alan D Cameron; J Michael Connor
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

6.  First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.

Authors:  K Spencer; N J Cowans; F Molina; K O Kagan; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2008-02       Impact factor: 7.299

7.  Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome.

Authors:  Yuval Yaron; Sigal Heifetz; Yifat Ochshorn; Ofer Lehavi; Avi Orr-Urtreger
Journal:  Prenat Diagn       Date:  2002-09       Impact factor: 3.050

8.  Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A.

Authors:  Natasa Tul; Stanko Pusenjak; Josko Osredkar; Kevin Spencer; Ziva Novak-Antolic
Journal:  Prenat Diagn       Date:  2003-12-15       Impact factor: 3.050

9.  Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.

Authors:  Kevin Spencer; Nicholas J Cowans; Kypros H Nicolaides
Journal:  Prenat Diagn       Date:  2008-01       Impact factor: 3.050

10.  Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.

Authors:  K Spencer; C K H Yu; M Savvidou; A T Papageorghiou; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2006-06       Impact factor: 7.299

View more
  16 in total

Review 1.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

2.  First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study.

Authors:  Anthony O Odibo; Katherine R Goetzinger; Linda Odibo; Alison G Cahill; George A Macones; D Michael Nelson; Dennis J Dietzen
Journal:  Prenat Diagn       Date:  2011-07-11       Impact factor: 3.050

3.  First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.

Authors:  A O Odibo; Y Zhong; M Longtine; M Tuuli; L Odibo; A G Cahill; G A Macones; D M Nelson
Journal:  Placenta       Date:  2011-02-13       Impact factor: 3.481

4.  Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.

Authors:  Suchaya Luewan; Monrudee Teja-Intr; Supatra Sirichotiyakul; Theera Tongsong
Journal:  Singapore Med J       Date:  2017-04-28       Impact factor: 1.858

5.  Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia.

Authors:  Katherine R Goetzinger; Yan Zhong; Alison G Cahill; Linda Odibo; George A Macones; Anthony O Odibo
Journal:  J Ultrasound Med       Date:  2013-09       Impact factor: 2.153

6.  Prediction of Preeclampsia by First Trimester Combined Test and Simple Complete Blood Count Parameters.

Authors:  Ayse Kirbas; Ali Ozgur Ersoy; Korkut Daglar; Turkan Dikici; Ebru Hacer Biberoglu; Ozgur Kirbas; Nuri Danisman
Journal:  J Clin Diagn Res       Date:  2015-11-01

7.  Development and validation of a risk factor scoring system for first-trimester prediction of preeclampsia.

Authors:  Katherine R Goetzinger; Methodius G Tuuli; Alison G Cahill; George A Macones; Anthony O Odibo
Journal:  Am J Perinatol       Date:  2014-04-04       Impact factor: 1.862

8.  Pilot Interventional Study Comparing Fetomaternal Outcomes of 150 mg Versus 75 mg Aspirin Starting Between 11 and 14 Weeks of Pregnancy in Patients with High Risk of Preeclampsia: A Randomized Control Trial.

Authors:  Namrata Kumar; Vinita Das; Anjoo Agarwal; Amita Pandey; Smriti Agrawal; Amrita Singh
Journal:  J Obstet Gynaecol India       Date:  2019-09-20

9.  Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.

Authors:  John Allotey; Kym Ie Snell; Melanie Smuk; Richard Hooper; Claire L Chan; Asif Ahmed; Lucy C Chappell; Peter von Dadelszen; Julie Dodds; Marcus Green; Louise Kenny; Asma Khalil; Khalid S Khan; Ben W Mol; Jenny Myers; Lucilla Poston; Basky Thilaganathan; Anne C Staff; Gordon Cs Smith; Wessel Ganzevoort; Hannele Laivuori; Anthony O Odibo; Javier A Ramírez; John Kingdom; George Daskalakis; Diane Farrar; Ahmet A Baschat; Paul T Seed; Federico Prefumo; Fabricio da Silva Costa; Henk Groen; Francois Audibert; Jacques Masse; Ragnhild B Skråstad; Kjell Å Salvesen; Camilla Haavaldsen; Chie Nagata; Alice R Rumbold; Seppo Heinonen; Lisa M Askie; Luc Jm Smits; Christina A Vinter; Per M Magnus; Kajantie Eero; Pia M Villa; Anne K Jenum; Louise B Andersen; Jane E Norman; Akihide Ohkuchi; Anne Eskild; Sohinee Bhattacharya; Fionnuala M McAuliffe; Alberto Galindo; Ignacio Herraiz; Lionel Carbillon; Kerstin Klipstein-Grobusch; SeonAe Yeo; Helena J Teede; Joyce L Browne; Karel Gm Moons; Richard D Riley; Shakila Thangaratinam
Journal:  Health Technol Assess       Date:  2020-12       Impact factor: 4.014

Review 10.  Preeclampsia: multiple approaches for a multifactorial disease.

Authors:  Kathleen A Pennington; Jessica M Schlitt; Daniel L Jackson; Laura C Schulz; Danny J Schust
Journal:  Dis Model Mech       Date:  2012-01       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.